Custom Antibody Market Size, Share, Trends, Growth 2032

Custom Antibody Market Insights

According to Zion Market Research, the global Custom Antibody Market was worth USD 527.1 Million in 2023. The market is forecast to reach USD 1130.94 Million by 2032, growing at a compound annual growth rate (CAGR) of 7.9% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Custom Antibody Market industry over the next decade.

Request Free Sample

Custom Antibody Market: Overview

Antibodies are produced in the human body of host in reaction to entry of foreign bodies. These foreign bodies are termed as antigen and are recorded by immune system of the body. Moreover, the natural body reaction to foreign bodies resulting in production of antibodies can then be used for producing custom antibodies targeted at certain kind of disease antigens for combating & eliminating them. In addition to this, custom antibodies provide more specificity in comparison to regular antibodies. Apart from this, custom antibodies can be produced easily as compared to any other kind of antibodies and hence are preferred more in performing various types of research activities.

Request Free Sample

Custom Antibody Market: Growth Factors

Surge in the research activities in Lifesciences & biotechnology along with rising industry-academia partnerships will culminate into huge market growth over the assessment period. Additionally, escalating awareness pertaining to personalized therapeutics is projected to embellish custom antibody market growth trends. Apart from this, massive requirement for substantial capital funding in research activities pertaining to production of antibodies will prompt the expansion of custom antibody industry over the forecast timeline.

Growing occurrence of contagious ailments will impel market demand in the years ahead. With monoclonal antibodies gaining humungous popularity in healthcare sector, custom antibody business is likely to accelerate in the upcoming years.

Custom Antibody Market: Report Scope

Custom Antibody Market: Regional Landscape

North America To Contribute Lucratively Towards Overall Market Size By 2032

The expansion of custom antibody industry in North America over 2024-2032 is due to large-scale investments by the private firms & government institutions in producing structure-based drugs. In addition to this, surge in the research activities in genomics & proteomics domains will expedite the regional market size over the projected timeframe. Apart from this, huge need for high quality research methods and focus on producing antibody-based healing methods will proliferate the regional market size over the coming years. Additionally, large presence of giant participants in the sub-continent will embellish the regional industry trends.

Custom Antibody Market Competitive Landscape

Key participants profiled in the study include

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• Merck Group
• Cell Signaling Technology Inc.
• GenScript
• BioLegend 
• Rockland Immunochemicals

The global Custom Antibody Market is segmented as follows:

By End-User

• Pharmaceutical Companies
• CRO’s

By Type

• Monoclonal
• Polyclonal
• Recombinant

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa